Back to list
Docking and target interactions · Small-molecule docking

Reverse target screening

Start from an anonymized small molecule and combine pocket-representation retrieval, structure preparation, batch docking and functional evidence to reduce the target-validation space.

Discuss your research question
Original scientific visual for Reverse target screening
01
OVERVIEW

What Reverse target screening is designed to address

Reverse target screening is not a one-score software run. It is a reviewable analysis path organised around “When no target is predefined, which proteins deserve structural and experimental review?”, beginning with input quality, comparators and intended use of evidence before selecting an appropriate methodological level.

The work centres on Protein-pocket and ligand-representation retrieval, Structure preparation, batch docking and distribution review, Cross-layer evidence intersection and functional enrichment and links Standardised small-molecule structure, Target species and protein scope, Optional phenotype, omics or prior mechanism clues directly to Source-traceable target tiers, Retrieval–structure–function evidence map, Representative candidates and experimental-validation suggestions. Reporting separates supporting evidence, conflicting signals, parameter dependence and conditions for follow-up validation.

When no target is predefined, which proteins deserve structural and experimental review?

Suitable research settings

  • Projects that need to answer “When no target is predefined, which proteins deserve structural and experimental review?”
  • Studies requiring consistent comparison and quality control across Protein-pocket and ligand-representation retrieval and Structure preparation, batch docking and distribution review
  • Teams that need Source-traceable target tiers, Retrieval–structure–function evidence map, Representative candidates and experimental-validation suggestions with complete reproduction records
02
SERVICE SCOPE

Analyses included in the service

Protein-pocket and ligand-representation retrieval

Apply Protein-pocket and ligand-representation retrieval to standardised small-molecule structure and produce source-traceable target tiers. First confirm that standardised small-molecule structure can support the downstream analysis.

Structure preparation, batch docking and distribution review

Apply Structure preparation, batch docking and distribution review to target species and protein scope and produce retrieval–structure–function evidence map. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.

Cross-layer evidence intersection and functional enrichment

Apply Cross-layer evidence intersection and functional enrichment to optional phenotype, omics or prior mechanism clues and produce representative candidates and experimental-validation suggestions. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.

03
METHOD SELECTION

Select the methodological level for the question

MethodBest suited toWatch for
Protein-pocket and ligand-representation retrievalEstablishing the input baseline and initial search space for Reverse target screeningErrors in Reverse target screening input state, structure or data definition propagate through later steps
Structure preparation, batch docking and distribution reviewComparing candidate states, features or mechanisms in Reverse target screening to form prioritiesReverse target screening comparisons require consistent conditions; raw scores are not experimental measurements
Cross-layer evidence intersection and functional enrichmentReviewing key Reverse target screening results, interpreting differences and recording uncertaintyRetrieval, docking and enrichment only raise validation priority; they do not establish direct binding, a true target or mechanism.
04
WORKFLOW

From question definition to reproducible delivery

  1. Frame the research question

    Use “When no target is predefined, which proteins deserve structural and experimental review?” to define comparators, decision use, experimental context and the strength of evidence the computation can support.

  2. Review and curate inputs

    Review Standardised small-molecule structure, Target species and protein scope, Optional phenotype, omics or prior mechanism clues; resolve structure, naming, unit, batch or microstate issues and record any remaining assumptions.

  3. Design methods and controls

    Combine Protein-pocket and ligand-representation retrieval, Structure preparation, batch docking and distribution review, Cross-layer evidence intersection and functional enrichment with controls, replicates, sensitivity checks or independent evidence, defining decision criteria before computation.

  4. Compute with quality control

    Run Reverse target screening, including Protein-pocket and ligand-representation retrieval, in a reproducible environment; retain inputs, versions, parameters, logs and intermediate outputs, and flag convergence, sampling, data-quality and applicability issues.

  5. Interpret and deliver

    Organise Source-traceable target tiers, Retrieval–structure–function evidence map, Representative candidates and experimental-validation suggestions while separating direct observations, model inference and working hypotheses, then prioritise experiments or follow-up computation.

05
INPUTS & DELIVERABLES

What is needed and what is delivered

Inputs

  • Standardised small-molecule structure
  • Target species and protein scope
  • Optional phenotype, omics or prior mechanism clues

Optional supporting inputs

  • Known positive, negative or reference systems for basic expectation checks in Reverse target screening
  • Replicate experiments, external databases or literature evidence relevant to Reverse target screening
  • Timing, compute, software-compatibility or delivery-format constraints for Reverse target screening

Deliverables

  • Source-traceable target tiers
  • Retrieval–structure–function evidence map
  • Representative candidates and experimental-validation suggestions
06
QUALITY CONTROL

Quality control and interpretation limits

How results are reviewed

  • Reverse target screening: Check structural integrity and chemical states of receptors, ligands or binding partners
  • Reverse target screening: Record site, restraint, flexibility, metal or covalent-reaction assumptions
  • Reverse target screening: Review sampling with known complexes, redocking or independent repeats
  • Reverse target screening: Check pose geometry, clashes, interactions and result stability

Boundaries that remain

  • Retrieval, docking and enrichment only raise validation priority; they do not establish direct binding, a true target or mechanism.
  • Reverse target screening results apply only to the recorded inputs, parameters, models and sampling scope. Changes to input state, comparison conditions or project objectives may require new computation.
07
PROJECT PATTERNS

Common ways projects begin

From one system to comparable candidates

When standardised small-molecule structure are available but decision criteria are inconsistent, establish baselines and controls, then use Protein-pocket and ligand-representation retrieval, Structure preparation, batch docking and distribution review, Cross-layer evidence intersection and functional enrichment to build candidate tiers and deliver source-traceable target tiers with a difference analysis.

Independent review of existing results

When results relevant to Reverse target screening conflict, revisit standardised small-molecule structure and analytical assumptions around Protein-pocket and ligand-representation retrieval, then add replicates, sensitivity checks or alternative models to distinguish signal from method conditions.

08
FAQ

Questions before a project begins

What is required before Reverse target screening begins?

The minimum inputs are Standardised small-molecule structure, Target species and protein scope, Optional phenotype, omics or prior mechanism clues. If information is incomplete, an input audit identifies which gaps change method selection and which can be handled as explicit assumptions.

Can the result directly prove “When no target is predefined, which proteins deserve structural and experimental review?”?

No single model output should be treated as experimental fact. Retrieval, docking and enrichment only raise validation priority; they do not establish direct binding, a true target or mechanism. Quality controls determine whether results support a priority or mechanism hypothesis; key conclusions still require appropriate experiments or independent data.

Which reusable files are delivered?

Typical delivery includes Source-traceable target tiers, Retrieval–structure–function evidence map, Representative candidates and experimental-validation suggestions, together with input-curation records, key parameters, software and database versions, quality-control results, editable figures and limitations. Exact raw formats are confirmed in the project plan.

START WITH THE QUESTION

Describe your research question and we will evaluate the right computational path

Start a project